Neurological Sciences

, Volume 37, Issue 4, pp 495–502 | Cite as

Review on clinical update of essential tremor

  • Wei Chunling
  • Xiao ZhengEmail author
Review Article


Essential tremor (ET) is considered a benign disease without any pathological changes. Nevertheless, this point of view has recently been challenged. In recent years, studies have shown that ET occurs with other non-motor symptoms, such as cognitive deficits, depression, anxiety, balance disorder, hearing impairment, olfactory dysfunction and sleep problems. Advancements in neuroimaging have revealed widespread alterations in the brain, and cerebellar involvement was the most consistent finding. In addition, studies have also shown that ET patients might experience poor quality of life, reflecting motor or non-motor symptoms. Both pharmacotherapy and non-pharmacotherapy have recently been suggested for the treatment of ET. This review briefly describes the current information on ET, including the non-movement symptoms, neuroimaging findings, the impact on daily life and ET therapy.


Essential tremor Non-motor symptoms Neuroimaging Quality of life Treatment 



The author would like to thank the medical research project of Chongqing Health and Family Planning Commission 2013-1-012. This work was financially supported through the National Clinical Key Specialty Construction Foundation of China.

Compliance with ethical standards

Conflict of interest

We have no any conflict of interest.


  1. 1.
    Lacerte A et al (2014) Increased prevalence of non-motor symptoms in essential tremor. Tremor Other Hyperkinet Mov (N Y) 4:162Google Scholar
  2. 2.
    Bhalsing KS, Saini J, Pal PK (2013) Understanding the pathophysiology of essential tremor through advanced neuroimaging: a review. J Neurol Sci 335(1–2):9–13CrossRefPubMedGoogle Scholar
  3. 3.
    Bermejo-Pareja F, Puertas-Martin V (2012) Cognitive features of essential tremor: a review of the clinical aspects and possible mechanistic underpinnings. Tremor Other Hyperkinet Mov (N Y) 2Google Scholar
  4. 4.
    Jankovic J (2002) Essential tremor: a heterogenous disorder. Mov Disord 17(4):638–644CrossRefPubMedGoogle Scholar
  5. 5.
    Arkadir D, Louis ED (2013) The balance and gait disorder of essential tremor: what does this mean for patients? Ther Adv Neurol Disord 6(4):229–236CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gasparini M et al (2001) Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol 248(5):399–402CrossRefPubMedGoogle Scholar
  7. 7.
    Sinoff G, Badarny S (2014) Mild cognitive impairment, dementia, and affective disorders in essential tremor: a prospective study. Tremor Other Hyperkinet Mov (N Y) 4:227Google Scholar
  8. 8.
    Bhalsing KS et al (2015) White matter correlates of cognitive impairment in essential tremor. Am J Neuroradiol 36(3):448–453CrossRefPubMedGoogle Scholar
  9. 9.
    Lombardi WJ et al (2001) Cognitive deficits in patients with essential tremor. Neurology 57(5):785–790CrossRefPubMedGoogle Scholar
  10. 10.
    Benito-Leon J, Louis ED, Bermejo-Pareja F (2006) Elderly-onset essential tremor is associated with dementia. Neurology 66(10):1500–1505CrossRefPubMedGoogle Scholar
  11. 11.
    Thawani SP, Schupf N, Louis ED (2009) Essential tremor is associated with dementia: prospective population-based study in New York. Neurology 73(8):621–625CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Louis ED (2010) Essential tremor as a neuropsychiatric disorder. J Neurol Sci 289(1–2):144–148CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Schneck CD, Buzan RD (2000) Mood disorders in neurologic illness. Curr Treat Options Neurol 2(2):151–168CrossRefPubMedGoogle Scholar
  14. 14.
    Fabbrini G et al (2012) Psychiatric disorders in patients with essential tremor. Parkinsonism Relat Disord 18(8):971–973CrossRefPubMedGoogle Scholar
  15. 15.
    Louis ED, Benito-Leon J, Bermejo-Pareja F (2007) Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol 14(10):1138–1146CrossRefPubMedGoogle Scholar
  16. 16.
    Chandran V et al (2012) Non-motor features in essential tremor. Acta Neurol Scand 125(5):332–337CrossRefPubMedGoogle Scholar
  17. 17.
    Dogu O et al (2005) Clinical characteristics of essential tremor in Mersin, Turkey–a population-based door-to-door study. J Neurol 252(5):570–574CrossRefPubMedGoogle Scholar
  18. 18.
    Li ZW et al (2011) Characteristics of depressive symptoms in essential tremor. J Clin Neurosci 18(1):52–56CrossRefPubMedGoogle Scholar
  19. 19.
    Miller KM et al (2007) Depression symptoms in movement disorders: comparing Parkinson’s disease, dystonia, and essential tremor. Mov Disord 22(5):666–672CrossRefPubMedGoogle Scholar
  20. 20.
    Jhunjhunwala K, Pal PK (2014) The non-motor features of essential tremor: a primary disease feature or just a secondary phenomenon? Tremor Other Hyperkinet Mov (N Y) 4:255Google Scholar
  21. 21.
    Sengul Y et al (2015) Cognitive functions, fatigue, depression, anxiety, and sleep disturbances: assessment of nonmotor features in young patients with essential tremor. Acta Neurol Belg 115:281–287CrossRefPubMedGoogle Scholar
  22. 22.
    Louis ED, Rios E, Rao AK (2010) Tandem gait performance in essential tremor: clinical correlates and association with midline tremors. Mov Disord 25(11):1633–1638CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lim ES et al (2005) Relationship between essential tremor and cerebellar dysfunction according to age. J Clin Neurol 1(1):76–80CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Roemmich RT et al (2013) Gait variability magnitude but not structure is altered in essential tremor. J Biomech 46(15):2682–2687CrossRefPubMedGoogle Scholar
  25. 25.
    Louis ED, Rao AK, Gerbin M (2012) Functional correlates of gait and balance difficulty in essential tremor: balance confidence, near misses and falls. Gait Posture 35(1):43–47CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Benito-Leon J et al (2007) Reported hearing impairment in essential tremor: a population-based case–control study. Neuroepidemiology 29(3–4):213–217CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Busenbark KL et al (1992) Olfactory function in essential tremor. Neurology 42(8):1631–1632CrossRefPubMedGoogle Scholar
  28. 28.
    Louis ED et al (2002) Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 59(10):1631–1633CrossRefPubMedGoogle Scholar
  29. 29.
    Applegate LM, Louis ED (2005) Essential tremor: mild olfactory dysfunction in a cerebellar disorder. Parkinsonism Relat Disord 11(6):399–402CrossRefPubMedGoogle Scholar
  30. 30.
    Lin CH et al (2013) VBM reveals brain volume differences between parkinson’s disease and essential tremor patients. Front Hum Neurosci 7:247CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Bagepally BS et al (2012) Decrease in cerebral and cerebellar gray matter in essential tremor: a voxel-based morphometric analysis under 3T MRI. J Neuroimaging 22(3):275–278CrossRefPubMedGoogle Scholar
  32. 32.
    Benito-Leon J et al (2009) Brain structural changes in essential tremor: voxel-based morphometry at 3-Tesla. J Neurol Sci 287(1–2):138–142CrossRefPubMedGoogle Scholar
  33. 33.
    Quattrone A et al (2008) Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. Am J Neuroradiol 29(9):1692–1697CrossRefPubMedGoogle Scholar
  34. 34.
    Martinelli P et al (2007) Diffusion-weighted imaging study of patients with essential tremor. Mov Disord 22(8):1182–1185CrossRefPubMedGoogle Scholar
  35. 35.
    Nicoletti G et al (2010) Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 74(12):988–994CrossRefPubMedGoogle Scholar
  36. 36.
    Saini J et al (2012) Diffusion tensor imaging: tract based spatial statistics study in essential tremor. Parkinsonism Relat Disord 18(5):477–482CrossRefPubMedGoogle Scholar
  37. 37.
    Shin DH et al (2008) Diffusion tensor imaging in patients with essential tremor. AJNR Am J Neuroradiol 29(1):151–153CrossRefPubMedGoogle Scholar
  38. 38.
    Louis ED et al (2002) Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 333(1):17–20CrossRefPubMedGoogle Scholar
  39. 39.
    Pagan FL et al (2003) Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 60(8):1344–1347CrossRefPubMedGoogle Scholar
  40. 40.
    Kendi AT et al (2005) Magnetic resonance spectroscopy of the thalamus in essential tremor patients. J Neuroimaging 15(4):362–366CrossRefPubMedGoogle Scholar
  41. 41.
    Novellino F et al (2013) Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. Mov Disord 28(2):196–200CrossRefPubMedGoogle Scholar
  42. 42.
    Contarino MF et al (2012) Is there a role for combined EMG-fMRI in exploring the pathophysiology of essential tremor and improving functional neurosurgery? PLoS One 7(10):e46234CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Passamonti L et al (2011) Altered cortical-cerebellar circuits during verbal working memory in essential tremor. Brain 134(Pt 8):2274–2286CrossRefPubMedGoogle Scholar
  44. 44.
    Colebatch JG et al (1990) Preliminary report: activation of the cerebellum in essential tremor. Lancet 336(8722):1028–1030CrossRefPubMedGoogle Scholar
  45. 45.
    Boecker H et al (1996) The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol 39(5):650–658CrossRefPubMedGoogle Scholar
  46. 46.
    Hallett M, Dubinsky RM (1993) Glucose metabolism in the brain of patients with essential tremor. J Neurol Sci 114(1):45–48CrossRefPubMedGoogle Scholar
  47. 47.
    Czarnecki K et al (2011) SPECT perfusion patterns distinguish psychogenic from essential tremor. Parkinsonism Relat Disord 17(5):328–332CrossRefPubMedGoogle Scholar
  48. 48.
    Louis ED, Okun MS (2011) It is time to remove the ‘benign’ from the essential tremor label. Parkinsonism Relat Disord 17(7):516–520CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Louis ED et al (2012) Depressive traits in essential tremor: impact on disability, quality of life, and medication adherence. Eur J Neurol 19(10):1349–1354CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Louis ED et al (2001) Correlates of functional disability in essential tremor. Mov Disord 16(5):914–920CrossRefPubMedGoogle Scholar
  51. 51.
    Woods SP et al (2008) Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremor. Cogn Behav Neurol 21(1):28–33CrossRefPubMedGoogle Scholar
  52. 52.
    Lorenz D et al (2011) The psychosocial burden of essential tremor in an outpatient- and a community-based cohort. Eur J Neurol 18(7):972–979CrossRefPubMedGoogle Scholar
  53. 53.
    Chandran V, Pal PK (2013) Quality of life and its determinants in essential tremor. Parkinsonism Relat Disord 19(1):62–65CrossRefPubMedGoogle Scholar
  54. 54.
    Rao AK, Gilman A, Louis ED (2014) Balance confidence and falls in nondemented essential tremor patients: the role of cognition. Arch Phys Med Rehabil 95(10):1832–1837CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Louis ED et al (2008) Philadelphia Geriatric Morale Scale in essential tremor: a population-based study in three Spanish communities. Mov Disord 23(10):1435–1440CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Rajput AH, Rajput A (2014) Medical treatment of essential tremor. J Cent Nerv Syst Dis 6:29–39CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Hedera P, Cibulcik F, Davis TL (2013) Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis 5:43–55CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Jankovic J et al (1996) A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 11(3):250–256CrossRefPubMedGoogle Scholar
  59. 59.
    Hertegard S, Granqvist S, Lindestad PA (2000) Botulinum toxin injections for essential voice tremor. Ann Otol Rhinol Laryngol 109(2):204–209CrossRefPubMedGoogle Scholar
  60. 60.
    Nahab FB et al (2012) Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics 9(3):635–638CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Bushara KO et al (2004) Pilot trial of 1-octanol in essential tremor. Neurology 62(1):122–124CrossRefPubMedGoogle Scholar
  62. 62.
    Haubenberger D et al (2013) Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology 80(10):933–940CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Shill HA et al (2004) Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 62(12):2320–2322CrossRefPubMedGoogle Scholar
  64. 64.
    Rajput AH et al (1975) Relative efficacy of alcohol and propranolol in action tremor. Can J Neurol Sci 2(1):31–35PubMedGoogle Scholar
  65. 65.
    Mostile G, Jankovic J (2010) Alcohol in essential tremor and other movement disorders. Mov Disord 25(14):2274–2284CrossRefPubMedGoogle Scholar
  66. 66.
    Chen XL et al (2012) Deep brain stimulation. Interv Neurology 1(3–4):200–212CrossRefGoogle Scholar
  67. 67.
    Pedrosa DJ et al (2014) Verbal fluency in essential tremor patients: the effects of deep brain stimulation. Brain Stimul 7(3):359–364CrossRefPubMedGoogle Scholar
  68. 68.
    Zappia M et al (2013) Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol 260(3):714–740CrossRefPubMedGoogle Scholar
  69. 69.
    Kumar R et al (2003) Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor. Neurology 61(11):1601–1604CrossRefPubMedGoogle Scholar
  70. 70.
    Baizabal-Carvallo JF et al (2014) The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry 85(5):567–572CrossRefPubMedGoogle Scholar
  71. 71.
    Chen R (2012) Repetitive transcranial magnetic stimulation as a treatment for essential tremor? Clin Neurophysiol 123(5):850–851CrossRefPubMedGoogle Scholar
  72. 72.
    Gironell A et al (2002) Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study. Arch Neurol 59(3):413–417CrossRefPubMedGoogle Scholar
  73. 73.
    Popa T et al (2013) Cerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: an open label trial. Brain Stimul 6(2):175–179CrossRefPubMedGoogle Scholar
  74. 74.
    Bologna M et al (2014) Cerebellar continuous theta burst stimulation in essential tremor. Cerebellum 14(2):133–141CrossRefGoogle Scholar
  75. 75.
    Schuurman PR et al (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342(7):461–468CrossRefPubMedGoogle Scholar
  76. 76.
    Ohye C et al (2002) Thalamic lesions produced by gamma thalamotomy for movement disorders. J Neurosurg 97(5 Suppl):600–606PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2016

Authors and Affiliations

  1. 1.Department of Neurology, The First Affiliated Hospital of Chongqing Medical UniversityChongqingChina
  2. 2.The Yongchuan Hospital of Chongqing Medical UniversityChongqingChina

Personalised recommendations